Fusion will be presenting at the JPM Healthcare Conference on Thursday at 11am PST! #JPM20

businesswire.com/news/home/2020…

Thank you Premier Doug Ford for coming to McMaster Innovation Park this afternoon to visit the McMaster Automotive Resource Centre #MARC , Biomedical Engineering and Advanced Manufacturing #BEAM Project Centre and Fusion Pharmaceuticals.

Come see our poster tomorrow at #ASCO2019 !!!
A Phase I study of [225Ac]-FPI-1434 radioimmunotherapy in patients with IGF-1R expressing solid tumors.
Saturday, June 1, 2019, 8:00 AM-11:00 AM CDT
McCormick Place, Hall A

McMaster University spin off company receives the largest single investment ever in a Canadian startup. This investment will contribute to Fusion Pharmaceuticals 's innovative cancer research & clinical trials

bit.ly/2Ib0WiN

We look forward to presenting our corporate update tomorrow (May 1st) at 11:30am at #BBHIC2019 in Toronto - please stop by! Bloom Burton & Co.

On Tuesday, I had an opportunity to once again congratulate Fusion Pharmaceuticals on their record $105 USD million investment at the McMaster Innovation Park McMaster University for research and aid in the development of cancer therapies.

McMaster-based Fusion Pharmaceuticals has received $105M (USD) in private financing to help develop new cancer therapies. Along with being an important step towards helping cancer patients, it's also good news for job creation and innovation in #hamont . bit.ly/2If6Hft

Proud day for McMaster University & #HamOnt : McMaster spinout Fusion Pharmaceuticals closed $105MM SeriesB round, largest private investment into a biotech company in Canada. Fusion does amazing work here at McMaster Innovation Park. An inspiration to all Canadian entrepreneurs. bloom.bg/2YI6sPE

Pleased to meet Minister @DrFullertonMPP this morning at the announcement of $100M USD in private financing for Fusion Pharmaceuticals ⚛ helping to develop new cancer treatments here @mip_hamilton This is a huge success for Hamilton EcDev McMaster University & #HamOnt

Today at MIP, Fusion Pharmaceuticals announced that they are the recipients of the largest single investment in the history of Canadian startups.

Check out the video for the full story:
buff.ly/2YOckHp

Congrats to portfolio company Fusion Pharmaceuticals on completing an impressive $105M Series B financing. Proud to help support this #Ontario #biotech grow in their #fightagainstcancer bit.ly/2UbzgSi

Actinide #isotopes are not only helping scientists expand the #periodictable , they’re also helping pioneer new #medical treatments.

Learn how actinium-225 from ORNL is being used to fight #cancer .

🔗 cen.acs.org/physical-chemi…

ICYMI No one treatment works on all cancers, and even within a single patient, cancer cells can behave differently. New probes that both treat and monitor cancer at the same time open new possibilities for personalized care: ow.ly/NYua30nUTsv McMaster University Fusion Pharmaceuticals

{Featured video} “How can I stop the disease? How can I shut it down? By understanding the molecules and the function of the disease on the inside, you can better select the best treatment for the disease.” ow.ly/egBs30nUSsx McMaster University Fusion Pharmaceuticals

Pleased to announce that John Crowley, CPA, has joined as CFO. Welcome John!
Fusion Pharmaceuticals
fusionpharma.com/fusion-pharmac…

Pleased to announce our first patient has been dosed with FPI-1434! Thank you to our employees, partners, and patients. Together we are changing the world of #TATs and #cancer treatment.
fusionpharma.com/fusion-pharma-…
U.S. Department of Energy @NSED_ORNL Oak Ridge Lab McMaster University ImmunoGen Ontario Institute for Cancer Research (OICR) #CPDC

We appreciate your hard work!